The Dissolution Procedure: Development and …
The Dissolution Procedure: Development and Validation Based on: <1092> as published in Pharmacopoeial Forum, Vol. 31 (5), 2005 Dr. …
Download The Dissolution Procedure: Development and …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ICH Topic Q 1 A Stability Testing Guidelines: …
www.pharma.gally.chCPMP/ICH/380/95 1/13 STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS ICH Harmonised Tripartite Guideline [EMEA Status as …
ICH Topic Q 3 A Impurities Testing Guideline: …
www.pharma.gally.chCPMP/ICH/142/95 1/11 IMPURITIES IN NEW DRUG SUBSTANCES ICH Harmonised Tripartite Guideline TABLE OF CONTENTS 1. Preamble 2 2. Classification of Impurities 2
ICH Topic Q 2 A Validation of Analytical Methods ...
www.pharma.gally.chCPMP/ICH/381/95 1/5 VALIDATION OF ANALYTICAL METHODS: DEFINITIONS AND TERMINOLOGY ICH Harmonised Tripartite Guideline …
ICH Q9 QUALITY RISK MANAGEMENT Quality Risk …
www.pharma.gally.chContent prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY RISK MANAGEMENT
5.10. CONTROL OF IMPURITIES IN SUBSTANCES …
www.pharma.gally.ch5.10. Impurities in substances for pharmaceutical use EUROPEAN PHARMACOPOEIA 5.0 It should be noted that specific thresholds are applied to substances exclusively for veterinary use.
Related documents
In Vitro Dissolution Testing for Solid Oral Dosage …
www.particlesciences.comthe USP recommended ionic strength.5 For APIs that exhibit low solubilities in aqueous me-dia throughout the pH range, the addition of surfactants is recom-mended.